sertraline has been researched along with Psychotic Disorders in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (21.62) | 18.2507 |
| 2000's | 10 (27.03) | 29.6817 |
| 2010's | 11 (29.73) | 24.3611 |
| 2020's | 8 (21.62) | 2.80 |
| Authors | Studies |
|---|---|
| de Meulenaere, J; De Proost, A | 1 |
| Alexopoulos, GS; Flint, AJ; Gerretsen, P; Marino, P; Meyers, BS; Mulsant, BH; Rothschild, AJ; Sanches, M; Song, J; Voineskos, AN; Whyte, EM | 1 |
| Alexopoulos, GS; Bingham, KS; Butters, MA; Calarco, N; Dickie, EW; Flint, AJ; Marino, P; Meyers, BS; Mulsant, BH; Neufeld, NH; Rothschild, AJ; Voineskos, AN; Whyte, EM | 1 |
| Al-Janabi, H; Au, P; Barnes, NM; Barnes, TRE; Birchwood, M; Drake, R; Giacco, D; Griffiths, SL; Husain, N; Katshu, MZUH; Major, B; Marriott, C; Ottridge, R; Palmer, ER; Patel, S; Sadiq, Z; Taylor, E; Tearne, S; Upthegrove, R; Walters, JTR; Watkins, B; Weetman, T; Woolley, R | 1 |
| Alexopoulos, GS; Dickie, EW; Flint, AJ; Hoptman, MJ; Lerch, JP; Meyers, BS; Mulsant, BH; Neufeld, NH; Rothschild, AJ; Voineskos, AN; Whyte, EM | 1 |
| Hernández-Salas, LP; Herrera-Huerta, CA; Magallanes-Cano, EM | 1 |
| Barbe, N; Coffey, BJ; Miller, M; Poulsen, RJ | 1 |
| Frankle, WG; Lequesne, E; Rohs, A; Zhang, E | 1 |
| Alexopoulos, GS; Artis, AS; Banerjee, S; Bingham, KS; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM | 1 |
| Coffey, DB; Gathright, MM; Holmes, KJ; Huynh, PN | 1 |
| Blumberger, DM; Flint, AJ; Kanellopoulos, D; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM | 1 |
| Bech, P; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Ulbricht, CM; Whyte, EM; Østergaard, SD | 1 |
| Davies, SJ; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM | 1 |
| Bies, RR; Davies, SJ; Flint, AJ; Kirshner, MM; Meyers, BS; Mulsant, BH; Pollock, BG; Rothschild, AJ; Sorisio, D; Whyte, EM | 2 |
| Beadles, BA; Byerly, M; Jha, MK; Lambert, ES; Martinez, R; Renfro, N; Spradling, B | 1 |
| Banerjee, S; Bingham, KS; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM | 1 |
| Alexopoulos, GS; Banerjee, S; Butters, MA; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Victoria, LW; Whyte, EM | 1 |
| Preskorn, SH | 1 |
| Flint, AJ; Heo, M; Leon, AC; Meyers, BS; Mulsant, BH; Papademetriou, E; Peasley-Miklus, C; Rothschild, AJ; Whyte, EM | 1 |
| Bilge, U; Erol, K | 1 |
| Benazzi, F | 1 |
| Ancione, M; D'Arrigo, C; Madia, A; Migliardi, G; Morgante, L; Spina, E; Zoccali, R | 1 |
| Addington, D; Addington, J; Patten, S; Pierson, K | 1 |
| Kuczynski, E; Thomé-Souza, MS; Valente, KD | 1 |
| LaPorta, LD | 1 |
| Rush, AJ; Suppes, T | 1 |
| Burke, WJ; Dewan, V; Folks, DG; Nadolny, GC; Roccaforte, WH; Wengel, SP | 1 |
| Dryden-Edwards, RC; Reiss, AL | 1 |
| Diaz, S; Howard, M; Jain, N; Pearlstein, T; Zlotnick, C | 1 |
| Lauterbach, EC | 1 |
| Caliskan, M; Kirli, S | 1 |
| Takhar, J; Williamson, P | 1 |
| Khan, A; Preskorn, SH; Shad, MU | 1 |
| Ancione, M; Avenoso, A; Facciolá, G; Madia, A; Salemi, M; Scordo, MG; Spina, E | 1 |
| Braus, DF; Schmitt, A | 1 |
| Kropp, S; Schlimme, J; Schneider, U | 1 |
1 review(s) available for sertraline and Psychotic Disorders
| Article | Year |
|---|---|
Dysphoric disorders in women: a case of perinatal depression.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Breast Feeding; Depression, Postpartum; Depressive Disorder; Female; Humans; Pregnancy; Pregnancy Complications; Psychotic Disorders; Sertraline | 1998 |
15 trial(s) available for sertraline and Psychotic Disorders
| Article | Year |
|---|---|
Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II Study.
Topics: Antipsychotic Agents; Benzodiazepines; Delusions; Depression; Drug Therapy, Combination; Humans; Olanzapine; Psychotic Disorders; Sertraline; Treatment Outcome | 2023 |
The relationship of white matter microstructure with psychomotor disturbance and relapse in remitted psychotic depression.
Topics: Anisotropy; Brain; Depression; Depressive Disorder, Major; Humans; Psychotic Disorders; Sertraline; White Matter | 2023 |
Antidepressants for the prevention of depression following first-episode psychosis (ADEPP): study protocol for a multi-centre, double-blind, randomised controlled trial.
Topics: Adult; Antidepressive Agents; Child, Preschool; Depression; Humans; Infant; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Psychotic Disorders; Quality of Life; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome | 2023 |
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Cerebral Cortex; Depressive Disorder, Major; Diffusion Tensor Imaging; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Psychotic Disorders; Sertraline; White Matter; Young Adult | 2020 |
The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression.
Topics: Age Factors; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Incidence; Middle Aged; Olanzapine; Prevalence; Psychotic Disorders; Risk Factors; Sertraline; Time Factors | 2013 |
Measuring treatment response in psychotic depression: the Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Sertraline; Treatment Outcome | 2014 |
Differential impact of anxiety symptoms and anxiety disorders on treatment outcome for psychotic depression in the STOP-PD study.
Topics: Antidepressive Agents; Antipsychotic Agents; Anxiety; Anxiety Disorders; Benzodiazepines; Depressive Disorder, Major; Female; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2014 |
The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD.
Topics: Adult; Aged; Benzodiazepines; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Models, Biological; Olanzapine; Psychotic Disorders; Sertraline; Sex Factors | 2015 |
Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cerebrovascular Disorders; Cognition; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Executive Function; Humans; Mental Processes; Middle Aged; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Reaction Time; Risk; Sertraline; Severity of Illness Index; Stroop Test; Treatment Outcome; Young Adult | 2015 |
Improvement in Depression is Associated with Improvement in Cognition in Late-Life Psychotic Depression.
Topics: Aged; Aged, 80 and over; Aging; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cognition; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Humans; Late Onset Disorders; Middle Aged; Olanzapine; Psychotic Disorders; Sertraline; Treatment Outcome | 2017 |
A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).
Topics: Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Humans; Olanzapine; Placebos; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2009 |
Plasma risperidone concentrations during combined treatment with sertraline.
Topics: Adult; Antipsychotic Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline | 2004 |
Serum monitoring of antipsychotic drug levels during concomitant administration of sertraline and antipsychotic medication.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Comorbidity; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Monitoring; Humans; Middle Aged; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
A comparative study of sertraline versus imipramine in postpsychotic depressive disorder of schizophrenia.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Plasma concentrations of clozapine and its major metabolites during combined treatment with paroxetine or sertraline.
Topics: Adult; Clozapine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Psychotic Disorders; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline | 2000 |
21 other study(ies) available for sertraline and Psychotic Disorders
| Article | Year |
|---|---|
[Psychosis in an adolescent girl treated with sertraline].
Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Female; Humans; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |
Cycloid psychosis and its longitudinal diagnosis: case report.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Female; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Psychotic Disorders; Recurrence; Risperidone; Sertraline; Sleep Initiation and Maintenance Disorders | 2020 |
Overcoming Complications in Management of a Difficult-to-Treat Adolescent with Schizoaffective Disorder.
Topics: Adolescent; Adolescent Psychiatry; Antidepressive Agents; Antipsychotic Agents; Diphenhydramine; Female; Haloperidol; Humans; Hypnotics and Sedatives; Lorazepam; Psychiatric Department, Hospital; Psychotic Disorders; Risperidone; Sertraline | 2020 |
Suspected Recurrence of Symptomatic COVID-19: Management During Inpatient Psychiatric Treatment.
Topics: Adult; Alcoholism; Antidepressive Agents; Antipsychotic Agents; Clozapine; COVID-19; COVID-19 Nucleic Acid Testing; Depressive Disorder, Major; Hospitals, Psychiatric; Humans; Inpatients; Male; Mirtazapine; Psychotic Disorders; Recurrence; SARS-CoV-2; Sertraline; Suicide, Attempted | 2021 |
Stabilization treatment of remitted psychotic depression: the STOP-PD study.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Placebos; Psychotic Disorders; Remission Induction; Sertraline; Triglycerides | 2018 |
Worsening psychosis after fever of unknown origin in an adolescent boy with autism.
Topics: Autistic Disorder; Child; Fever of Unknown Origin; Humans; Male; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline | 2013 |
A Case of Frontotemporal Dementia Presenting With Treatment-Refractory Psychosis and Extreme Violence: Response to Combination of Clozapine, Medroxyprogesterone, and Sertraline.
Topics: Adult; Clozapine; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Frontotemporal Dementia; Humans; Male; Medroxyprogesterone; Psychotic Disorders; Serotonin Agents; Sertraline; Violence | 2015 |
SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study.
Topics: Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Olanzapine; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors | 2016 |
Practical application of therapeutic drug monitoring: a tale of two patients.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Drug Interactions; Female; Humans; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 2008 |
Effects of sertraline on experimental mouse models of psychosis.
Topics: Animals; Antidepressive Agents; Apomorphine; Catalepsy; Dextroamphetamine; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Haloperidol; Mice; Motor Activity; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2012 |
Psychotic mania in bipolar II depression related to sertraline discontinuation.
Topics: Adult; Bipolar Disorder; Female; Humans; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 2002 |
Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression.
Topics: Adolescent; Child; Child, Preschool; Depression; Epilepsy; Female; Fluoxetine; Humans; Male; Neurologic Examination; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 2007 |
Sertraline-induced akathisia.
Topics: 1-Naphthylamine; Akathisia, Drug-Induced; Arousal; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Middle Aged; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Medication optimization during clozapine treatment.
Topics: 1-Naphthylamine; Adult; Clozapine; Drug Therapy, Combination; Humans; Lithium; Male; Obsessive-Compulsive Disorder; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Valproic Acid | 1996 |
The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychotic Disorders; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Differential response of psychotic and obsessive symptoms to risperidone in an adolescent.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Hallucinations; Haloperidol; Humans; Male; Obsessive-Compulsive Disorder; Psychotic Disorders; Risperidone; Sertraline; Trifluoperazine | 1996 |
Catatonia-like events after valproic acid with risperidone and sertraline.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Catatonia; Drug Interactions; Drug Therapy, Combination; Female; Globus Pallidus; Humans; Psychotic Disorders; Risperidone; Sertraline; Valproic Acid | 1998 |
Hypoglycemia associated with high doses of sertraline and sulphonylurea compound in a noninsulin-dependent diabetes mellitus patient.
Topics: Adult; Antidepressive Agents, Second-Generation; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Psychotic Disorders; Sertraline; Sulfonylurea Compounds | 1999 |
Lack of sertraline efficacy probably due to an interaction with carbamazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Female; Humans; Male; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Treatment Outcome | 2000 |
[Effective treatment of depressive disorder with psychotic symptoms by olanzapine combination therapy].
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Psychotic Disorders; Sertraline; Treatment Outcome | 2000 |
Psychotic depression, subcortical arteriosclerotic encephalopathy and holocaust-conditioned posttraumatic stress disorder.
Topics: Aged; Dementia, Vascular; Depressive Disorder; Female; Holocaust; Humans; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic | 2001 |